Chairman and CEO Hong Zhi increased his holdings in BRII-B (02137) by 58,000 shares at a price of approximately 1.02 Hong Kong dollars per share.
On September 23, Chairman and CEO Hong Zhi of the board of directors increased his holdings of Tengsheng Pharmaceutical-B (02137) by 58,000 shares, with a price of 1.0195 Hong Kong dollars per share, totaling approximately 59,100 Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on September 23, the Chairman of the Board and CEO, Hong Zhi, increased his holdings of BRII-B (02137) by 58,000 shares at a price of 1.0195 Hong Kong dollars per share, with a total amount of approximately 59,100 Hong Kong dollars. After the increase, the latest number of shares held is approximately 54.5678 million shares, with a new shareholding ratio of 7.46%.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


